European Journal of Nuclear Medicine

, Volume 17, Issue 5, pp 201–202 | Cite as

Systemic radiotherapy

  • Diana Tait


  1. O'Donoghue JA, Wheldon, TE, Babich JW, Moyes JSE, Barrett A, Meller ST (1990) Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma. (abstract) The Fifth Symposium on Neuroblastoma Research, Philadelphia, May 1990Google Scholar
  2. Flower MA, Schlesinger T, Hinton PJ, Adam I, Masoomi AM, Elbelli MA, Ott RJ, McReady VR, Harmer CL (1989) Radiation dose assessment in radioiodine therapy — Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother, Oncol 15:345–357Google Scholar
  3. Fowler JF (1990) Radiobiological aspects of low dose rates in radioimmunotherapy. Int J Radiat Oncol Biol Phys 18:1261–1269Google Scholar
  4. Buchsbaum DJ, Randell K, Heidorn DB, Larence TS, Glatfelter AA, Terry VH, Guilbault DM, Steplewski Z, Lichter AS (1990) A comparison of 1311-Labelled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS 174T human colon carcinoma xenografts. Int J Radiat Oncol Biol Phys 18:1033–1041Google Scholar
  5. Order SE (1990) Presidential address: Systemic radiotherapy - the new frontier. Int J Radiat Oncol Biol Phys 18:981–992Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • Diana Tait
    • 1
  1. 1.Royal Marsden HospitalSutton, SurreyUK

Personalised recommendations